Potentially curative treatment in patients with hepatocellular cancer-results from the liver cancer research network-Reference-Cited by-同舟云学术

Potentially curative treatment in patients with hepatocellular cancer-results from the liver cancer research network

Published:2012-06-07 Issue:3 Volume:36 Page:257-265
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kanwal F.,Befeler A.¹,Chari R. S.²,Marrero J.³,Kahn J.⁴,Afdhal N.⁵,Morgan T.,Roberts L.⁶,Mohanty S. R.⁷,Schwartz J.⁸,VanThiel D.⁹,Li J.¹⁰,Zeringue A.¹⁰,Di'Bisceglie A.¹

Affiliation:

1. Division of Gastroenterology and Hepatology; St Louis University School of Medicine; St Louis; MO; USA

2. Division of Liver Transplantation and Hepatobiliary Surgery; Vanderbilt University Medical Center; Nashville; TN; USA

3. Division of Gastroenterology and Hepatology; University of Michigan; Ann Arbor; MI; USA

4. Division of Gastrointestinal and Liver Diseases; Keck School of Medicine; University of Southern California; Los Angeles; CA; USA

5. Beth Israel Deaconess Medical Center and Harvard Medical School; Boston; MA; USA

6. Division of Gastroenterology and Hepatology; Mayo Clinic College of Medicine; Rochester; MN; USA

7. Section of Gastroenterology and Center for Liver Diseases; University of Chicago; Chicago; IL; USA

8. Oregon Health and Science University; Portland; OR; USA

9. Rush University Medical Center; Chicago; IL; USA

10. John Cochran VA Medical Center; Saint Louis; MO; USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2012.05174.x/fullpdf

Reference18 articles.

1. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

3. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999

4. Surgery for hepatocellular carcinoma: does it improve survival?;Liu;Ann Surg Oncol,2004

5. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet;Semin Liver Dis,1999

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization;Frontiers in Oncology;2024-03-28

2. Preoperative detection of hepatocellular carcinoma's microvascular invasion on CT-scan by machine learning and radiomics: A preliminary analysis;European Journal of Surgical Oncology;2024-03

3. Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysis;BMC Cancer;2024-02-09

4. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis;Cancer Epidemiology, Biomarkers & Prevention;2024-01-22

5. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis;Health Technology Assessment;2023-12